BlackRock, Inc. - Jun 30, 2025 SCHEDULE 13G/A Report for ENLIVEN THERAPEUTICS INC Common Stock (ELVN)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: ENLIVEN THERAPEUTICS INC Common Stock
Symbol: ELVN
Shares outstanding: 57.7M shares
Disclosed Ownership: 2.94M shares
Ownership: 5.1%
Form type: SCHEDULE 13G/A
Date filed: 7/17/2025, 07:54 PM
Date of event: Jun 30, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	5.1%	2.94M	2.89M	0	Spencer Fleming	Managing Director